| Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA. CMYWTIDM 120. S. C. Johnson, P. Amarenco, H. Denison, S. Evans, A ... The New England Journal of Medicine 383, 207-217, 2020 | 492 | 2020 |
| Opicapone as an anjunct to levodopa in patients with Parkinson’s disease and end-of-dose motor fluctuations: a randomized, double-blind, controlled trial B 92. Ferreira JJ, Lees A, Rocha J-F, Poewe W, Rakol O, Soares-da-Silva P ... Lancet Neurology, 2015 | 274* | 2015 |
| Randomized trial of preladenant, given as monotherapy, in patients with early Parkinson disease. DMOPEPDSG F. Stocchi, O. Rascol, R. A. Hauser, S. Huyck, A. Tzontcheva, R ... Neurology, 2017 | 67 | 2017 |
| Efficacy and safety of extended‐release oxcarbazepine (Oxtellar XR™) as adjunctive therapy in patients with refractory partial‐onset seizures: a randomized controlled trial JA French, P Baroldi, ST Brittain, JK Johnson, ... Acta neurologica scandinavica 129 (3), 143-153, 2014 | 52 | 2014 |
| Risk for major bleeding in patients receiving ticagrelor compared with aspirin after transient ischemic attack or acute ischemic stroke in the SOCRATES study (Acute stroke or … JD Easton, M Aunes, GW Albers, P Amarenco, S Bokelund-Singh, ... Circulation 136 (10), 907-916, 2017 | 35 | 2017 |
| Ticagrelor added to aspirin in acute ischemic stroke or transient ischemic attack in prevention of disabling stroke: a randomized clinical trial P Amarenco, H Denison, SR Evans, A Himmelmann, S James, ... JAMA neurology 78 (2), 177-185, 2021 | 31 | 2021 |
| Solar and geomagnetic activity and acute myocardial infarction morbidity and mortality S Dimitrova, I Stoilova, K Georgieva, T Taseva, M Jordanova, D Maslarov Vasc. Dis 8 (9), 2009 | 27 | 2009 |
| Efficacy and safety of ticagrelor and aspirin in patients with moderate ischemic stroke: an exploratory analysis of the THALES randomized clinical trial Y Wang, Y Pan, H Li, P Amarenco, H Denison, SR Evans, A Himmelmann, ... JAMA neurology 78 (9), 1091-1098, 2021 | 23 | 2021 |
| Analysis of therapeutic efficacy of citicoline in patients with vertigo of central origin and vascular aetiology D Petrova, D Maslarov, I Angelov, D Zekin American Journal of Neuroprotection and Neuroregeneration 4 (1), 78-85, 2012 | 17 | 2012 |
| Long‐term efficacy and safety of eslicarbazepine acetate monotherapy for adults with newly diagnosed focal epilepsy: An open‐label extension study E Trinka, R Rocamora, J Chaves, J Moreira, F Ikedo, P Soares‐da‐Silva, ... Epilepsia 61 (10), 2129-2141, 2020 | 7 | 2020 |
| Effects of citicoline on neuropsychological status after stroke DB Maslarov International Journal of Psychophysiology 100 (108), 94, 2016 | 5 | 2016 |
| Presence and levels of anti-GM3 antibodies and GM3 ganglioside molecules in probes from experimental in vitro-models V Kolyovska, I Sainova, S Dimitrova, I Ivanova-Pandourska, R Eneva, ... Biochem. Molec. Biol. J 4 (2), 18, 2018 | 4 | 2018 |
| Preclinic and clinic effectiveness of gabapentin and pregabalin for treatment of neuropathic pain in rats and diabetic patients S Surcheva, L Todorova, D Maslarov, M Vlaskovska Biotechnology & Biotechnological Equipment 31 (3), 568-573, 2017 | 4 | 2017 |
| Use of Nattokinase in Patients with Ischemic Stroke and Transient Ischemic Attacks DD Dimitar Maslarov Neurology & Neuroscience 1 (2), 1-5, 2020 | 3 | 2020 |
| Neurodegenerative changes in serum IgG antibodies to GD1a, GM1 and GM3 gangliosides in aging rats V Kolyovska, V Pavlova, I Iliev, Y Dokova, D Maslarov American Journal of Neuroprotection and Neuroregeneration 7 (1), 72-74, 2015 | 3 | 2015 |
| Serum IgG antibodies to GM1, GM3 and GD1a gangliosides in patients with relapsing remitting multiple sclerosis under treatment with Interferon, Copaxone and Laquinimod … V Kolyovska, D Maslarov, I Dokova, S Todorov, I Iliev, S Engibarov, ... Acta morphologica et anthropologica, 62, 2014 | 3 | 2014 |
| Pharmacogenomic assessment of clopidogrel—/INS; A step toward personalized medicine for patients with ischemic stroke D Maslarov, D Drenska, O Micova, L Todorova, M Vlaskovska Journal of the Neurological Sciences 333, e262-e263, 2013 | 3 | 2013 |
| New perspectives in multiple sclerosis treatment V Kolyovska, S Todorov, D Maslarov, V Kolyovska Medical Data 5 (3), 241-244, 2013 | 3 | 2013 |
| First Multiprofile Hospital for Active Treatment D Maslarov Bulgaria, 0 | 3 | |
| Role of GM3 ganglioside in the pathology of some progressive human diseases and prognostic importance of serum anti-GM3 antibodies V Kolyovska, S Ivanova, D Drenska, D Maslarov, R Toshkova Biocell 45 (6), 1485, 2021 | 2 | 2021 |
Velichka Pavlova, PhDTchaikapharma High Quality Medicines在 tchaikapharma.com 的电子邮件经过验证
